Search research articles
Contact Us
Filters
Showing results (321-330 of 391) with videos related to
Page
of 40
Sort By:
Leukemia
|
August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
K C Goh, V Novotny-Diermayr, S Hart, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
H J Gray, B Benigno, J Berek, et al.
European Urology Focus
|
January 9, 2024
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
Arsalan Tariq, Adam Pearce, Handoo Rhee, et al.
British Journal of Pharmacology
|
July 25, 2017
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
Mei S Ong, Wanpei Cai, Yi Yuan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2023
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
Shivanshan Pathmanathan, Arsalan Tariq, Adam Pearce, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2018
Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)
Kristina Lindemann, Philip J Beale, Emma Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.
Leukemia
|
June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies
S Hart, K C Goh, V Novotny-Diermayr, et al.
JCI Insight
|
August 18, 2017
Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner
Soohyun P Kim, Zhu Li, Meredith L Zoch, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 391) with videos related to
Sort By:
Page
of 40
Leukemia
|
August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
K C Goh, V Novotny-Diermayr, S Hart, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2016
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
H J Gray, B Benigno, J Berek, et al.
European Urology Focus
|
January 9, 2024
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours: Initial Experience in a Multicentre Cohort
Arsalan Tariq, Adam Pearce, Handoo Rhee, et al.
British Journal of Pharmacology
|
July 25, 2017
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling
Mei S Ong, Wanpei Cai, Yi Yuan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 17, 2023
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
Shivanshan Pathmanathan, Arsalan Tariq, Adam Pearce, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2018
Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)
Kristina Lindemann, Philip J Beale, Emma Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.
Leukemia
|
June 22, 2011
SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies
S Hart, K C Goh, V Novotny-Diermayr, et al.
JCI Insight
|
August 18, 2017
Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner
Soohyun P Kim, Zhu Li, Meredith L Zoch, et al.
Page
of 40